Similar articles

• Position of Subcutaneous Implantable Cardioverter-Defibrillators and Possible Interference on Myocardial Perfusion Imaging.

  Kahaly OR, Shafiei F, Hardebeck C, Houmsse M. Kahaly OR, et al. Tex Heart Inst J. 2017 Jun 1;44(3):223-225. doi: 10.14503/THIJ-16-5921. eCollection 2017 Jun. Tex Heart Inst J. 2017. PMID: 28761406 Free PMC article.
• Attenuation artifact, attenuation correction, and the future of myocardial perfusion SPECT.

  Singh B, Bateman TM, Case JA, Heller G. Singh B, et al. J Nucl Cardiol. 2007 Apr;14(2):153-64. doi: 10.1016/j.nuclcard.2007.01.037. J Nucl Cardiol. 2007. PMID: 17386377 No abstract available.
• Effects of pacemaker, implantable cardioverter-defibrillator, and left ventricular leads on CT-based attenuation correction.

  Suzuki A, Koshida K, Matsubara K. Suzuki A, et al. J Nucl Med Technol. 2014 Mar;42(1):37-41. doi: 10.2967/jnmt.113.133736. Epub 2014 Jan 24. J Nucl Med Technol. 2014. PMID: 24463340
• Review of the linogram and sinogram: an easy way to detect off-peak artifacts in myocardial perfusion SPECT.

  Mommennezhad M, Zakavi SR, Sadeghi R, Kakhki VR. Mommennezhad M, et al. J Nucl Med Technol. 2009 Sep;37(3):188-90. doi: 10.2967/jnmt.108.061218. Epub 2009 Aug 19. J Nucl Med Technol. 2009. PMID: 19692451 Review.
• Attenuation correction: eternal dilemma or real improvement?

  Hendel RC. Hendel RC. Q J Nucl Med Mol Imaging. 2005 Mar;49(1):30-42. Q J Nucl Med Mol Imaging. 2005. PMID: 15724134 Review.